Skip to the page

Data / Form D filings / Diligent Pharma, Inc.

Diligent Pharma, Inc.: Form D filing

Diligent Pharma, Inc., a technology company in Princeton, NJ, filed a Form D with the SEC in 2023. The latest, on February 16, 2023, reports $3.5 million sold of a $9.3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
179 NASSAU STREET, SUITE 3A, Princeton, NJ, 08542
Phone
(609) 610-2815
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1965661

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 16, 2023New notice$9,250,000$3,500,000$5,750,0002Feb 2, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Patricia LeuchtenExecutive Officer

Other technology companies in New Jersey that filed recently

Every Form D from the week of Feb 13, 2023 · All recent filings in New Jersey · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Diligent Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.